Thursday, September 12 at 12:00 PM EDT

Counterfeit drugs found in the healthcare supply chain are rising and pose a significant risk to patient safety. Healthcare executives need a cohesive strategy to monitor the pharmaceutical supply chain from manufacturing all the way to patient administration.  This webinar will explore the FDA’s Drug Supply Chain Security Act (DSCSA) that recently went into effect, and how current and emerging technologies are addressing pain points throughout the entire supply chain. Attendees will learn about the findings of an end-to-end pharmaceutical supply chain pilot study conducted by The Axia Institute, that included 16 industry participants across major pharmaceutical manufacturers, wholesalers, dispensers and technology providers.

Speakers

Bahar Aliakbarian, Senior Director of Research & Development, Axia Institute – Michigan State University
Gee Mathen, Director of Application and Technical Services, Pharmacy Financial Services, and Pharmacy Inventory, Texas Children’s Hospital
John Wirthlin, Principal Owner, Tip of the Spear Consulting
We look forward to seeing you on September 12th!